Xenon Pharmaceuticals Inc. 4
4 · Xenon Pharmaceuticals Inc. · Filed Mar 14, 2017
Insider Transaction Report
Form 4
COHEN CHARLES J.
VP, Biology
Transactions
- Award
Stock Option (Right to Buy)
2017-03-13+20,000→ 20,000 totalExercise: $8.40Exp: 2027-03-12→ Common Shares (20,000 underlying)
Footnotes (1)
- [F1]Vesting 25% on January 1, 2018, and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month.